Wellington Wealth Strategies LLC. Buys Shares of 1,782 Agilent Technologies, Inc. (NYSE:A)

Wellington Wealth Strategies LLC. purchased a new position in shares of Agilent Technologies, Inc. (NYSE:A) during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 1,782 shares of the medical research company’s stock, valued at approximately $231,000.

Several other institutional investors and hedge funds also recently made changes to their positions in A. Crewe Advisors LLC raised its position in Agilent Technologies by 114.8% during the 2nd quarter. Crewe Advisors LLC now owns 189 shares of the medical research company’s stock worth $25,000 after purchasing an additional 101 shares during the last quarter. Livelsberger Financial Advisory acquired a new stake in shares of Agilent Technologies in the fourth quarter valued at about $26,000. Ridgewood Investments LLC bought a new position in shares of Agilent Technologies during the second quarter worth about $29,000. Rise Advisors LLC lifted its stake in shares of Agilent Technologies by 527.8% in the first quarter. Rise Advisors LLC now owns 226 shares of the medical research company’s stock worth $33,000 after acquiring an additional 190 shares during the period. Finally, YHB Investment Advisors Inc. bought a new stake in Agilent Technologies in the first quarter valued at approximately $34,000. Institutional investors and hedge funds own 87.42% of the company’s stock.

Analyst Upgrades and Downgrades

A has been the subject of several analyst reports. Evercore ISI raised their price target on shares of Agilent Technologies from $130.00 to $135.00 and gave the stock an “in-line” rating in a report on Thursday, August 22nd. TD Cowen lifted their target price on shares of Agilent Technologies from $153.00 to $160.00 and gave the stock a “buy” rating in a research note on Thursday, August 22nd. Stifel Nicolaus reaffirmed a “buy” rating and set a $151.00 price target on shares of Agilent Technologies in a research report on Monday, August 26th. Bank of America increased their price target on Agilent Technologies from $140.00 to $147.00 and gave the stock a “neutral” rating in a report on Thursday, August 22nd. Finally, Barclays boosted their price objective on Agilent Technologies from $125.00 to $135.00 and gave the company an “underweight” rating in a research note on Friday, August 23rd. One analyst has rated the stock with a sell rating, five have assigned a hold rating and nine have issued a buy rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $142.93.

Insiders Place Their Bets

In related news, CEO Padraig Mcdonnell sold 1,958 shares of the stock in a transaction on Thursday, August 22nd. The stock was sold at an average price of $145.00, for a total value of $283,910.00. Following the completion of the sale, the chief executive officer now directly owns 24,118 shares of the company’s stock, valued at approximately $3,497,110. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. In other Agilent Technologies news, SVP Dominique Grau sold 9,990 shares of Agilent Technologies stock in a transaction that occurred on Thursday, September 26th. The shares were sold at an average price of $145.00, for a total transaction of $1,448,550.00. Following the transaction, the senior vice president now owns 40,011 shares of the company’s stock, valued at approximately $5,801,595. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Padraig Mcdonnell sold 1,958 shares of the business’s stock in a transaction that occurred on Thursday, August 22nd. The stock was sold at an average price of $145.00, for a total value of $283,910.00. Following the completion of the transaction, the chief executive officer now owns 24,118 shares in the company, valued at approximately $3,497,110. The disclosure for this sale can be found here. In the last ninety days, insiders sold 13,906 shares of company stock valued at $2,006,580. Corporate insiders own 0.33% of the company’s stock.

Agilent Technologies Price Performance

Shares of NYSE:A opened at $148.06 on Monday. Agilent Technologies, Inc. has a twelve month low of $96.80 and a twelve month high of $155.35. The stock’s 50 day moving average is $138.91 and its 200-day moving average is $138.99. The company has a quick ratio of 1.37, a current ratio of 1.78 and a debt-to-equity ratio of 0.36. The firm has a market capitalization of $43.20 billion, a price-to-earnings ratio of 35.00, a PEG ratio of 6.48 and a beta of 1.05.

Agilent Technologies (NYSE:A) last released its quarterly earnings data on Wednesday, August 21st. The medical research company reported $1.32 earnings per share for the quarter, beating analysts’ consensus estimates of $1.26 by $0.06. The firm had revenue of $1.58 billion for the quarter, compared to analyst estimates of $1.56 billion. Agilent Technologies had a net margin of 21.75% and a return on equity of 25.26%. The business’s quarterly revenue was down 5.6% compared to the same quarter last year. During the same period last year, the firm earned $1.43 earnings per share. Sell-side analysts forecast that Agilent Technologies, Inc. will post 5.24 EPS for the current fiscal year.

Agilent Technologies Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, October 23rd. Shareholders of record on Tuesday, October 1st will be paid a dividend of $0.236 per share. The ex-dividend date is Tuesday, October 1st. This represents a $0.94 dividend on an annualized basis and a yield of 0.64%. Agilent Technologies’s dividend payout ratio (DPR) is currently 22.22%.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.